Bulletin
Investor Alert

New York Markets After Hours

Company Close Updates Archives | Email alerts

Oct. 27, 2020, 6:08 p.m. EDT

Moderna Inc. stock rises Tuesday, still underperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA inched 0.61% higher to $70.67 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.64% to 11,431.35 and the Dow Jones Industrial Average DJIA falling 0.80% to 27,463.19. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $24.54 below its 52-week high ($95.21), which the company reached on July 17th.

The stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV fell 1.44% to $82.71, Amgen Inc. AMGN fell 0.64% to $223.46, and AstraZeneca PLC ADR AZN fell 1.11% to $52.48. Trading volume (3.8 M) remained 4.8 million below its 50-day average volume of 8.6 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.